Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa.

van der Hoek W, Sarge-Njie R, Herremans T, Chisnall T, Okebe J, Oriero E, Versteeg B, Goossens B, van der Sande M, Kampmann B, Nwakanma D.

Trop Med Int Health. 2013 Jul;18(7):850-3. doi: 10.1111/tmi.12116. Epub 2013 Apr 19.

2.

Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa.

Stewart B, Jobarteh ML, Sarge-Njie R, Alabi A, de Silva T, Peterson K, Peterson I, Whittle H, Rowland-Jones S, Jaye A, Cotten M, Mendy M.

BMC Res Notes. 2011 Dec 23;4:561. doi: 10.1186/1756-0500-4-561.

3.

Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.

de Silva TI, Aasa-Chapman M, Cotten M, Hué S, Robinson J, Bibollet-Ruche F, Sarge-Njie R, Berry N, Jaye A, Aaby P, Whittle H, Rowland-Jones S, Weiss R.

J Virol. 2012 Jan;86(2):930-46. doi: 10.1128/JVI.06126-11. Epub 2011 Nov 9.

4.

Maternal proviral load and vertical transmission of human T cell lymphotropic virus type 1 in Guinea-Bissau.

van Tienen C, McConkey SJ, de Silva TI, Cotten M, Kaye S, Sarge-Njie R, da Costa C, Gonçalves N, Parker J, Vincent T, Jaye A, Aaby P, Whittle H, Schim van der Loeff M.

AIDS Res Hum Retroviruses. 2012 Jun;28(6):584-90. doi: 10.1089/AID.2011.0219. Epub 2012 Mar 9.

PMID:
22066980
5.

Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.

Choi Y, Townend J, Vincent T, Zaidi I, Sarge-Njie R, Jaye A, Clifford DB.

J Neurovirol. 2011 Apr;17(2):166-75. doi: 10.1007/s13365-011-0022-9. Epub 2011 Mar 22.

6.

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.

Jobarteh M, Malfroy M, Peterson I, Jeng A, Sarge-Njie R, Alabi A, Peterson K, Cotten M, Hall A, Rowland-Jones S, Whittle H, Tedder R, Jaye A, Mendy M.

Virol J. 2010 Sep 15;7:230. doi: 10.1186/1743-422X-7-230.

7.

HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007.

van Tienen C, van der Loeff MF, Peterson I, Cotten M, Holmgren B, Andersson S, Vincent T, Sarge-Njie R, Rowland-Jones S, Jaye A, Aaby P, Whittle H.

Retrovirology. 2010 Jun 4;7:50. doi: 10.1186/1742-4690-7-50.

8.

Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.

van der Loeff MF, Larke N, Kaye S, Berry N, Ariyoshi K, Alabi A, van Tienen C, Leligdowicz A, Sarge-Njie R, da Silva Z, Jaye A, Ricard D, Vincent T, Jones SR, Aaby P, Jaffar S, Whittle H.

Retrovirology. 2010 May 19;7:46. doi: 10.1186/1742-4690-7-46.

9.

Two distinct epidemics: the rise of HIV-1 and decline of HIV-2 infection between 1990 and 2007 in rural Guinea-Bissau.

Tienen Cv, van der Loeff MS, Zaman SM, Vincent T, Sarge-Njie R, Peterson I, Leligdowicz A, Jaye A, Rowland-Jones S, Aaby P, Whittle H.

J Acquir Immune Defic Syndr. 2010 Apr;53(5):640-7. doi: 10.1097/QAI.0b013e3181bf1a25.

PMID:
19841588
10.

Declining trend of serological syphilis among genitourinary medicine patients in the Gambia, West Africa.

Hontelez JA, van der Loeff MF, Peterson I, Peterson K, Ahadzie B, Cotten M, Sarge-Njie R, Whittle H.

Sex Transm Dis. 2009 Dec;36(12):745-9. doi: 10.1097/OLQ.0b013e3181af6de0.

PMID:
19704397
11.

Presence of a multidrug-resistance mutation in an HIV-2 variant infecting a treatment-naive individual in Caio, Guinea Bissau.

Jallow S, Vincent T, Leligdowicz A, De Silva T, Van Tienen C, Alabi A, Sarge-Njie R, Aaby P, Corrah T, Whittle H, Jaye A, Vanham G, Rowland-Jones S, Janssens W.

Clin Infect Dis. 2009 Jun 15;48(12):1790-3. doi: 10.1086/599107.

PMID:
19438401
12.

Virological response to highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 2 (HIV-2) and in patients dually infected with HIV-1 and HIV-2 in the Gambia and emergence of drug-resistant variants.

Jallow S, Alabi A, Sarge-Njie R, Peterson K, Whittle H, Corrah T, Jaye A, Cotten M, Vanham G, McConkey SJ, Rowland-Jones S, Janssens W.

J Clin Microbiol. 2009 Jul;47(7):2200-8. doi: 10.1128/JCM.01654-08. Epub 2009 May 6.

13.

Neurological morbidity among human T-lymphotropic-virus-type-1-infected individuals in a rural West African population.

Cooper S, van der Loeff MS, McConkey S, Cooper M, Sarge-Njie R, Kaye S, Whittle H.

J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):66-8. doi: 10.1136/jnnp.2008.152819. Epub 2008 Oct 31.

PMID:
18977823
14.

Is HIV-2-induced AIDS different from HIV-1-associated AIDS?

Schim van der Loeff MF, Martinez-Steele E, Corrah T, Awasana AA, van der Sande M, Sarge-Njie R, McConkey S, Jaye A, Whittle H.

AIDS. 2008 Mar 30;22(6):791-2. doi: 10.1097/QAD.0b013e3282f37824. No abstract available.

PMID:
18356612
15.

Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection.

Leligdowicz A, Yindom LM, Onyango C, Sarge-Njie R, Alabi A, Cotten M, Vincent T, da Costa C, Aaby P, Jaye A, Dong T, McMichael A, Whittle H, Rowland-Jones S.

J Clin Invest. 2007 Oct;117(10):3067-74.

16.

Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic.

Martinez-Steele E, Awasana AA, Corrah T, Sabally S, van der Sande M, Jaye A, Togun T, Sarge-Njie R, McConkey SJ, Whittle H, Schim van der Loeff MF.

AIDS. 2007 Jan 30;21(3):317-24.

PMID:
17255738
17.

Evaluation of the dried blood spot filter paper technology and five testing strategies of HIV-1 and HIV-2 infections in West Africa.

Sarge-Njie R, Schim Van Der Loeff M, Ceesay S, Cubitt D, Sabally S, Corrah T, Whittle H.

Scand J Infect Dis. 2006;38(11-12):1050-6.

PMID:
17148076
18.

Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.

Jallow S, Kaye S, Alabi A, Aveika A, Sarge-Njie R, Sabally S, Corrah T, Whittle H, Vanham G, Rowland-Jones S, Janssens W, McConkey SJ.

AIDS. 2006 Jun 26;20(10):1455-8. No abstract available.

PMID:
16791023
19.

Sixteen years of HIV surveillance in a West African research clinic reveals divergent epidemic trends of HIV-1 and HIV-2.

van der Loeff MF, Awasana AA, Sarge-Njie R, van der Sande M, Jaye A, Sabally S, Corrah T, McConkey SJ, Whittle HC.

Int J Epidemiol. 2006 Oct;35(5):1322-8. Epub 2006 Mar 16.

PMID:
16543363
20.

CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.

Gillespie GM, Pinheiro S, Sayeid-Al-Jamee M, Alabi A, Kaye S, Sabally S, Sarge-Njie R, Njai H, Joof K, Jaye A, Whittle H, Rowland-Jones S, Dorrell L.

Eur J Immunol. 2005 May;35(5):1445-53.

21.

Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia.

Hansmann A, Schim van der Loeff MF, Kaye S, Awasana AA, Sarge-Njie R, O'Donovan D, Ariyoshi K, Alabi A, Milligan P, Whittle HC.

J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):335-41.

PMID:
15735454
22.

Dual HIV-1 and HIV-2 infection in a West African infant.

van der Sande MA, Luong TN, Schim van der Loeff MF, Sabally S, Aveika AA, Corrah T, Sarge-Njie R, Kaye S, Whittle HC.

Ann Trop Paediatr. 2004 Sep;24(3):277-8. No abstract available.

PMID:
15479581
23.

Body mass index at time of HIV diagnosis: a strong and independent predictor of survival.

van der Sande MA, Schim van der Loeff MF, Aveika AA, Sabally S, Togun T, Sarge-Njie R, Alabi AS, Jaye A, Corrah T, Whittle HC.

J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1288-94.

PMID:
15385737
24.

Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2.

van der Sande MA, Schim van der Loeff MF, Bennett RC, Dowling M, Aveika AA, Togun TO, Sabally S, Jeffries D, Adegbola RA, Sarge-Njie R, Jaye A, Corrah T, McConkey S, Whittle HC.

AIDS. 2004 Sep 24;18(14):1933-41.

PMID:
15353979
25.

No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.

Jaye A, Sarge-Njie R, Schim van der Loeff M, Todd J, Alabi A, Sabally S, Corrah T, Whittle H.

J Infect Dis. 2004 Feb 1;189(3):498-505. Epub 2004 Jan 21.

PMID:
14745708
26.

Survival of HIV-1 and HIV-2 perinatally infected children in The Gambia.

Schim van der Loeff MF, Hansmann A, Awasana AA, Ota MO, O'Donovan D, Sarge-Njie R, Ariyoshi K, Milligan P, Whittle H.

AIDS. 2003 Nov 7;17(16):2389-94.

PMID:
14571192
27.

Regional differences in HIV trends in The Gambia: results from sentinel surveillance among pregnant women.

Schim van der Loeff MF, Sarge-Njie R, Ceesay S, Awasana AA, Jaye P, Sam O, Jaiteh KO, Cubitt D, Milligan P, Whittle HC.

AIDS. 2003 Aug 15;17(12):1841-6.

PMID:
12891071
28.

Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients.

Alabi AS, Jaffar S, Ariyoshi K, Blanchard T, Schim van der Loeff M, Awasana AA, Corrah T, Sabally S, Sarge-Njie R, Cham-Jallow F, Jaye A, Berry N, Whittle H.

AIDS. 2003 Jul 4;17(10):1513-20.

PMID:
12824789

Supplemental Content

Loading ...
Support Center